Literature DB >> 27143657

Asymptomatic migration of an AMPLATZER™ Amulet™ left atrial appendage occluder through the mitral valve.

Petru Mester1, Antoine Dompnier1, Loïc Belle1.   

Abstract

An 84-year-old woman with a history of hemorrhagic stroke was admitted for a new cerebral ischemic event. While in hospital, she was diagnosed with paroxysmal atrial fibrillation. Owing to her high thromboembolic risk (CHA2 DS2 -VASc score of 6) we performed left atrial appendage (LAA) closure using a 22-mm AMPLATZER™ Amulet™. The procedure was successful. Systematic follow-up with transthoracic echocardiography 8 hr later revealed that the LAA occluder had migrated and become entrapped in the mitral subvalvular apparatus. At this time, the patient was asymptomatic. The device was recovered percutaneously using a loop-snare catheter, with no further complications.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  anticoagulants/antithrombins; catheterization; closure; coil/device/transcatheter; embolization; foreign body retrieval; left atrial appendage; transseptal

Mesh:

Year:  2016        PMID: 27143657     DOI: 10.1002/ccd.26557

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  3 in total

1.  Successful Left Atrial Appendage Occlusion with the New Generation Amulet® Device after Late-Occurring Embolization of an Amplatzer® Cardiac Plug in a Patient with Repetitive Strokes.

Authors:  Marco R Schroeter; Wolfgang Schillinger
Journal:  Case Rep Cardiol       Date:  2016-10-09

2.  Non-Pharmacologic Approach to Prevent Embolization in Patients with Atrial Fibrillation in Whom Anticoagulation is Contraindicated.

Authors:  Munish Sharma; Koroush Khalighi
Journal:  Clin Pract       Date:  2017-01-18

3.  Device embolization into the LV following left atrial endage closure with an Amplatzer Amulet.

Authors:  Krzysztof Kaczmarek; Bartosz Czarniak; Piotr Jakubowski; Pawel Ptaszynski
Journal:  J Interv Card Electrophysiol       Date:  2018-05-03       Impact factor: 1.900

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.